A randomised phase 2 trial of intensive induction chemotherapy (CBOP/BEP) and standard BEP in poor-prognosis germ cell tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604). (2015)

First Author: Huddart RA
Attributed to:  CANCER: Trials with potential global reach and other challenging trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.eururo.2014.06.034

PubMed Identifier: 25001888

Publication URI: http://europepmc.org/abstract/MED/25001888

Type: Journal Article/Review

Volume: 67

Parent Publication: European urology

Issue: 3

ISSN: 0302-2838